Hear experts' takeaways from ACOG 2025 on menopause care, postpartum depression screening, and obesity management.
Nanette F Santoro, MD
Advertisement
Articles by Nanette F Santoro, MD
The nonhormonal neurokinin-3 receptor antagonist improved menopausal adiposity without appreciable impact on body weight or BMI, Santoro explained at 2025 ACOG meeting.
Advertisement
Latest Updated Articles
Women’s Health Takeaways for Primary Care: Expert Insights From ACOG 2025Published: June 6th 2025 | Updated:
Nanette Santoro, MD, Highlights Findings on Fezolinetant From Pooled Analysis of Phase 3 Skylight Development Program TrialsPublished: May 19th 2025 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
EASO Recommends GLP-1 Agonists as First-Line Treatment for Obesity and Complications
2
FMX 2025 Day 1 Preview: 16 Can’t Miss Sessions for Primary Care Physicians
3
Precision Medicine Protocol for Cognitive Decline Also Reduces Depression, New Data Suggest
4
